The global market for Plasma Protein Therapeutics was estimated to be worth US$ 28070 million in 2023 and is forecast to a readjusted size of US$ 44730 million by 2030 with a CAGR of 6.8% during the forecast period 2024-2030

Plasma Protein Therapeutics - Market

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Shire (Baxalta), CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, which take about 55% market share. China is the major region of the global market, which takes about 45% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Plasma Protein Therapeutics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Plasma Protein Therapeutics by region & country, by Type, and by Application.

The Plasma Protein Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Protein Therapeutics.

Market Segmentation

Scope of Plasma Protein Therapeutics - Market Report

Report Metric	Details
Report Name	Plasma Protein Therapeutics - Market
Forecasted market size in 2030	US$ 44730 million
CAGR	6.8%
Forecasted years	2024 - 2030
Segment by Type:	Coagulation Factor Immune Globulin Albumin Others
Segment by Application	Hemophilia PID Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Shire (Baxalta), CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Kamada
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Plasma Protein Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Plasma Protein Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Plasma Protein Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Plasma Protein Therapeutics - Market size in 2030?

Ans: The Plasma Protein Therapeutics - Market size in 2030 will be US$ 44730 million.

What is the Plasma Protein Therapeutics - Market share by region?

Ans: China is the major region of the global market, which takes about 45% market share.

Who are the main players in the Plasma Protein Therapeutics - Market report?

Ans: The main players in the Plasma Protein Therapeutics - Market are Shire (Baxalta), CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Kamada

What are the Application segmentation covered in the Plasma Protein Therapeutics - Market report?

Ans: The Applications covered in the Plasma Protein Therapeutics - Market report are Hemophilia, PID, Others

What are the Type segmentation covered in the Plasma Protein Therapeutics - Market report?

Ans: The Types covered in the Plasma Protein Therapeutics - Market report are Coagulation Factor, Immune Globulin, Albumin, Others

1 Market Overview

1.1 Plasma Protein Therapeutics Product Introduction

1.2 Global Plasma Protein Therapeutics Market Size Forecast

1.2.1 Global Plasma Protein Therapeutics Sales Value (2019-2030)

1.2.2 Global Plasma Protein Therapeutics Sales Volume (2019-2030)

1.2.3 Global Plasma Protein Therapeutics Sales Price (2019-2030)

1.3 Plasma Protein Therapeutics Market Trends & Drivers

1.3.1 Plasma Protein Therapeutics Industry Trends

1.3.2 Plasma Protein Therapeutics Market Drivers & Opportunity

1.3.3 Plasma Protein Therapeutics Market Challenges

1.3.4 Plasma Protein Therapeutics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Plasma Protein Therapeutics Players Revenue Ranking (2023)

2.2 Global Plasma Protein Therapeutics Revenue by Company (2019-2024)

2.3 Global Plasma Protein Therapeutics Players Sales Volume Ranking (2023)

2.4 Global Plasma Protein Therapeutics Sales Volume by Company Players (2019-2024)

2.5 Global Plasma Protein Therapeutics Average Price by Company (2019-2024)

2.6 Key Manufacturers Plasma Protein Therapeutics Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Plasma Protein Therapeutics Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Plasma Protein Therapeutics

2.9 Plasma Protein Therapeutics Market Competitive Analysis

2.9.1 Plasma Protein Therapeutics Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Plasma Protein Therapeutics Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protein Therapeutics as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Coagulation Factor

3.1.2 Immune Globulin

3.1.3 Albumin

3.1.4 Others

3.2 Global Plasma Protein Therapeutics Sales Value by Type

3.2.1 Global Plasma Protein Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Plasma Protein Therapeutics Sales Value, by Type (2019-2030)

3.2.3 Global Plasma Protein Therapeutics Sales Value, by Type (%) (2019-2030)

3.3 Global Plasma Protein Therapeutics Sales Volume by Type

3.3.1 Global Plasma Protein Therapeutics Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Plasma Protein Therapeutics Sales Volume, by Type (2019-2030)

3.3.3 Global Plasma Protein Therapeutics Sales Volume, by Type (%) (2019-2030)

3.4 Global Plasma Protein Therapeutics Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hemophilia

4.1.2 PID

4.1.3 Others

4.2 Global Plasma Protein Therapeutics Sales Value by Application

4.2.1 Global Plasma Protein Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Plasma Protein Therapeutics Sales Value, by Application (2019-2030)

4.2.3 Global Plasma Protein Therapeutics Sales Value, by Application (%) (2019-2030)

4.3 Global Plasma Protein Therapeutics Sales Volume by Application

4.3.1 Global Plasma Protein Therapeutics Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Plasma Protein Therapeutics Sales Volume, by Application (2019-2030)

4.3.3 Global Plasma Protein Therapeutics Sales Volume, by Application (%) (2019-2030)

4.4 Global Plasma Protein Therapeutics Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Plasma Protein Therapeutics Sales Value by Region

5.1.1 Global Plasma Protein Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Plasma Protein Therapeutics Sales Value by Region (2019-2024)

5.1.3 Global Plasma Protein Therapeutics Sales Value by Region (2025-2030)

5.1.4 Global Plasma Protein Therapeutics Sales Value by Region (%), (2019-2030)

5.2 Global Plasma Protein Therapeutics Sales Volume by Region

5.2.1 Global Plasma Protein Therapeutics Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Plasma Protein Therapeutics Sales Volume by Region (2019-2024)

5.2.3 Global Plasma Protein Therapeutics Sales Volume by Region (2025-2030)

5.2.4 Global Plasma Protein Therapeutics Sales Volume by Region (%), (2019-2030)

5.3 Global Plasma Protein Therapeutics Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Plasma Protein Therapeutics Sales Value, 2019-2030

5.4.2 North America Plasma Protein Therapeutics Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Plasma Protein Therapeutics Sales Value, 2019-2030

5.5.2 Europe Plasma Protein Therapeutics Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Plasma Protein Therapeutics Sales Value, 2019-2030

5.6.2 Asia Pacific Plasma Protein Therapeutics Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Plasma Protein Therapeutics Sales Value, 2019-2030

5.7.2 South America Plasma Protein Therapeutics Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Plasma Protein Therapeutics Sales Value, 2019-2030

5.8.2 Middle East & Africa Plasma Protein Therapeutics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Plasma Protein Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Plasma Protein Therapeutics Sales Value

6.2.1 Key Countries/Regions Plasma Protein Therapeutics Sales Value, 2019-2030

6.2.2 Key Countries/Regions Plasma Protein Therapeutics Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Plasma Protein Therapeutics Sales Value, 2019-2030

6.3.2 United States Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Plasma Protein Therapeutics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Plasma Protein Therapeutics Sales Value, 2019-2030

6.4.2 Europe Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Plasma Protein Therapeutics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Plasma Protein Therapeutics Sales Value, 2019-2030

6.5.2 China Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Plasma Protein Therapeutics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Plasma Protein Therapeutics Sales Value, 2019-2030

6.6.2 Japan Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Plasma Protein Therapeutics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Plasma Protein Therapeutics Sales Value, 2019-2030

6.7.2 South Korea Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Plasma Protein Therapeutics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Plasma Protein Therapeutics Sales Value, 2019-2030

6.8.2 Southeast Asia Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Plasma Protein Therapeutics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Plasma Protein Therapeutics Sales Value, 2019-2030

6.9.2 India Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Plasma Protein Therapeutics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Shire (Baxalta)

7.1.1 Shire (Baxalta) Company Information

7.1.2 Shire (Baxalta) Introduction and Business Overview

7.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Shire (Baxalta) Plasma Protein Therapeutics Product Offerings

7.1.5 Shire (Baxalta) Recent Development

7.2 CSL

7.2.1 CSL Company Information

7.2.2 CSL Introduction and Business Overview

7.2.3 CSL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.2.4 CSL Plasma Protein Therapeutics Product Offerings

7.2.5 CSL Recent Development

7.3 Grifols

7.3.1 Grifols Company Information

7.3.2 Grifols Introduction and Business Overview

7.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Grifols Plasma Protein Therapeutics Product Offerings

7.3.5 Grifols Recent Development

7.4 Octapharma

7.4.1 Octapharma Company Information

7.4.2 Octapharma Introduction and Business Overview

7.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Octapharma Plasma Protein Therapeutics Product Offerings

7.4.5 Octapharma Recent Development

7.5 Kedrion

7.5.1 Kedrion Company Information

7.5.2 Kedrion Introduction and Business Overview

7.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Kedrion Plasma Protein Therapeutics Product Offerings

7.5.5 Kedrion Recent Development

7.6 LFB Group

7.6.1 LFB Group Company Information

7.6.2 LFB Group Introduction and Business Overview

7.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.6.4 LFB Group Plasma Protein Therapeutics Product Offerings

7.6.5 LFB Group Recent Development

7.7 Biotest

7.7.1 Biotest Company Information

7.7.2 Biotest Introduction and Business Overview

7.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Biotest Plasma Protein Therapeutics Product Offerings

7.7.5 Biotest Recent Development

7.8 BPL

7.8.1 BPL Company Information

7.8.2 BPL Introduction and Business Overview

7.8.3 BPL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.8.4 BPL Plasma Protein Therapeutics Product Offerings

7.8.5 BPL Recent Development

7.9 RAAS

7.9.1 RAAS Company Information

7.9.2 RAAS Introduction and Business Overview

7.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.9.4 RAAS Plasma Protein Therapeutics Product Offerings

7.9.5 RAAS Recent Development

7.10 CBPO

7.10.1 CBPO Company Information

7.10.2 CBPO Introduction and Business Overview

7.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.10.4 CBPO Plasma Protein Therapeutics Product Offerings

7.10.5 CBPO Recent Development

7.11 Hualan Bio

7.11.1 Hualan Bio Company Information

7.11.2 Hualan Bio Introduction and Business Overview

7.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Hualan Bio Plasma Protein Therapeutics Product Offerings

7.11.5 Hualan Bio Recent Development

7.12 Kamada

7.12.1 Kamada Company Information

7.12.2 Kamada Introduction and Business Overview

7.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Kamada Plasma Protein Therapeutics Product Offerings

7.12.5 Kamada Recent Development

8 Industry Chain Analysis

8.1 Plasma Protein Therapeutics Industrial Chain

8.2 Plasma Protein Therapeutics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Plasma Protein Therapeutics Sales Model

8.5.2 Sales Channel

8.5.3 Plasma Protein Therapeutics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Plasma Protein Therapeutics Market Trends

Table 2. Plasma Protein Therapeutics Market Drivers & Opportunity

Table 3. Plasma Protein Therapeutics Market Challenges

Table 4. Plasma Protein Therapeutics Market Restraints

Table 5. Global Plasma Protein Therapeutics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Plasma Protein Therapeutics Revenue Market Share by Company (2019-2024)

Table 7. Global Plasma Protein Therapeutics Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Plasma Protein Therapeutics Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Plasma Protein Therapeutics Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Plasma Protein Therapeutics Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Plasma Protein Therapeutics Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Plasma Protein Therapeutics

Table 13. Global Plasma Protein Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protein Therapeutics as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Plasma Protein Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Plasma Protein Therapeutics Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Plasma Protein Therapeutics Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Plasma Protein Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Plasma Protein Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Plasma Protein Therapeutics Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Plasma Protein Therapeutics Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Plasma Protein Therapeutics Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Plasma Protein Therapeutics Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Plasma Protein Therapeutics Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Plasma Protein Therapeutics Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Plasma Protein Therapeutics Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Plasma Protein Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Plasma Protein Therapeutics Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Plasma Protein Therapeutics Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Plasma Protein Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Plasma Protein Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Plasma Protein Therapeutics Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Plasma Protein Therapeutics Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Plasma Protein Therapeutics Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Plasma Protein Therapeutics Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Plasma Protein Therapeutics Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Plasma Protein Therapeutics Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Plasma Protein Therapeutics Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Plasma Protein Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Plasma Protein Therapeutics Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Plasma Protein Therapeutics Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Plasma Protein Therapeutics Sales Value by Region (2019-2024) & (%)

Table 44. Global Plasma Protein Therapeutics Sales Value by Region (2025-2030) & (%)

Table 45. Global Plasma Protein Therapeutics Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Plasma Protein Therapeutics Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Plasma Protein Therapeutics Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Plasma Protein Therapeutics Sales Volume by Region (2019-2024) & (%)

Table 49. Global Plasma Protein Therapeutics Sales Volume by Region (2025-2030) & (%)

Table 50. Global Plasma Protein Therapeutics Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Plasma Protein Therapeutics Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Plasma Protein Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Plasma Protein Therapeutics Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Plasma Protein Therapeutics Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Plasma Protein Therapeutics Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Plasma Protein Therapeutics Sales Volume, (2025-2030) & (K Units)

Table 57. Shire (Baxalta) Company Information

Table 58. Shire (Baxalta) Introduction and Business Overview

Table 59. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Shire (Baxalta) Plasma Protein Therapeutics Product Offerings

Table 61. Shire (Baxalta) Recent Development

Table 62. CSL Company Information

Table 63. CSL Introduction and Business Overview

Table 64. CSL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. CSL Plasma Protein Therapeutics Product Offerings

Table 66. CSL Recent Development

Table 67. Grifols Company Information

Table 68. Grifols Introduction and Business Overview

Table 69. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Grifols Plasma Protein Therapeutics Product Offerings

Table 71. Grifols Recent Development

Table 72. Octapharma Company Information

Table 73. Octapharma Introduction and Business Overview

Table 74. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Octapharma Plasma Protein Therapeutics Product Offerings

Table 76. Octapharma Recent Development

Table 77. Kedrion Company Information

Table 78. Kedrion Introduction and Business Overview

Table 79. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Kedrion Plasma Protein Therapeutics Product Offerings

Table 81. Kedrion Recent Development

Table 82. LFB Group Company Information

Table 83. LFB Group Introduction and Business Overview

Table 84. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. LFB Group Plasma Protein Therapeutics Product Offerings

Table 86. LFB Group Recent Development

Table 87. Biotest Company Information

Table 88. Biotest Introduction and Business Overview

Table 89. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Biotest Plasma Protein Therapeutics Product Offerings

Table 91. Biotest Recent Development

Table 92. BPL Company Information

Table 93. BPL Introduction and Business Overview

Table 94. BPL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. BPL Plasma Protein Therapeutics Product Offerings

Table 96. BPL Recent Development

Table 97. RAAS Company Information

Table 98. RAAS Introduction and Business Overview

Table 99. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. RAAS Plasma Protein Therapeutics Product Offerings

Table 101. RAAS Recent Development

Table 102. CBPO Company Information

Table 103. CBPO Introduction and Business Overview

Table 104. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. CBPO Plasma Protein Therapeutics Product Offerings

Table 106. CBPO Recent Development

Table 107. Hualan Bio Company Information

Table 108. Hualan Bio Introduction and Business Overview

Table 109. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Hualan Bio Plasma Protein Therapeutics Product Offerings

Table 111. Hualan Bio Recent Development

Table 112. Kamada Company Information

Table 113. Kamada Introduction and Business Overview

Table 114. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. Kamada Plasma Protein Therapeutics Product Offerings

Table 116. Kamada Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Plasma Protein Therapeutics Downstream Customers

Table 120. Plasma Protein Therapeutics Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Plasma Protein Therapeutics Product Picture

Figure 2. Global Plasma Protein Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Plasma Protein Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Plasma Protein Therapeutics Sales Volume (2019-2030) & (K Units)

Figure 5. Global Plasma Protein Therapeutics Sales Price (2019-2030) & (USD/Unit)

Figure 6. Plasma Protein Therapeutics Report Years Considered

Figure 7. Global Plasma Protein Therapeutics Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Plasma Protein Therapeutics Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Plasma Protein Therapeutics Revenue in 2023

Figure 10. Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Coagulation Factor Picture

Figure 12. Immune Globulin Picture

Figure 13. Albumin Picture

Figure 14. Others Picture

Figure 15. Global Plasma Protein Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Plasma Protein Therapeutics Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Plasma Protein Therapeutics Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Plasma Protein Therapeutics Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Plasma Protein Therapeutics Price by Type (2019-2030) & (USD/Unit)

Figure 20. Product Picture of Hemophilia

Figure 21. Product Picture of PID

Figure 22. Product Picture of Others

Figure 23. Global Plasma Protein Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Plasma Protein Therapeutics Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Plasma Protein Therapeutics Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 26. Global Plasma Protein Therapeutics Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Plasma Protein Therapeutics Price by Application (2019-2030) & (USD/Unit)

Figure 28. North America Plasma Protein Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Plasma Protein Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Plasma Protein Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Plasma Protein Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Plasma Protein Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Plasma Protein Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Plasma Protein Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Plasma Protein Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Plasma Protein Therapeutics Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Plasma Protein Therapeutics Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Plasma Protein Therapeutics Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Plasma Protein Therapeutics Sales Volume (%), (2019-2030)

Figure 40. United States Plasma Protein Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Plasma Protein Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Plasma Protein Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Plasma Protein Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 46. China Plasma Protein Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 48. China Plasma Protein Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Plasma Protein Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Plasma Protein Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Plasma Protein Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Plasma Protein Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Plasma Protein Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Plasma Protein Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 58. India Plasma Protein Therapeutics Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Plasma Protein Therapeutics Sales Value by Type (%), 2023 VS 2030

Figure 60. India Plasma Protein Therapeutics Sales Value by Application (%), 2023 VS 2030

Figure 61. Plasma Protein Therapeutics Industrial Chain

Figure 62. Plasma Protein Therapeutics Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions